AI Takeaway
Ventas (VTR) delivered strong FY2025 results with revenue surging 18.5% to $5.83B and EPS more than doubling to $0.55, driven by robust operating cash flow growth of 23.8% and a meaningful reduction in total liabilities.
Revenue
$5.83B
++18.47% YoY
EPS (Basic)
$0.55
++175.00% YoY
Filed · Analysis updated · Source: SEC EDGAR 10-K filing
VTR posted revenue of $5.83B in FY2025, up 18.5% from $4.92B in the prior year, reflecting strong demand across its senior housing and healthcare real estate portfolio as occupancy and rental rates improved.
Source: Source: 10-K Income Statement (XBRL Financial Data)
Basic EPS rose 175% year-over-year to $0.55 (from $0.20), and diluted EPS jumped 184% to $0.54, indicating materially improved profitability and operational leverage across the portfolio.
Source: Source: 10-K Income Statement (XBRL Financial Data)
Operating cash flow grew 23.8% to $1.65B from $1.33B, demonstrating the company's ability to convert revenue growth into cash and supporting ongoing dividend obligations and capital reinvestment.
Source: Source: 10-K Cash Flow Statement (XBRL Financial Data)
2 more insights available
Upgrade to unlockWith long-term debt of $13.01B and a debt-to-equity ratio of approximately 1.17, VTR carries significant leverage. As a REIT with large floating or refinanceable debt obligations, rising or sustained high interest rates could increase borrowing costs and pressure funds from operations.
Source: Source: 10-K Balance Sheet (XBRL Financial Data)
Unlock 4 more detailed risk analysis
Upgrade to unlockReported EPS of $0.15 versus the $0.08 analyst consensus — a +76.9% beat for FY2025.
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $5.83B | $4.92B | +18.47% |
EPS (Basic) | $0.55 | $0.20 | +175.00% |
EPS (Diluted) | $0.54 | $0.19 | +184.21% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $27.59B | $26.19B | +5.37% |
Total Liabilities | $14.63B | $15.05B | -2.77% |
Stockholders' Equity | $12.53B | $10.77B | +16.30% |
Cash & Equivalents | $741.07M | $897.85M | -17.46% |
Long-Term Debt | $13.01B | $13.52B | -3.78% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $1.65B | $1.33B | +23.85% |
Investing Cash Flow | $-2.69B | $-2.38B | -13.35% |
Financing Cash Flow | $873.76M | $1.45B | -39.54% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Debt to Equity | $1.168 | — | — |
Other companies in Health Care REITs
VTR's revenue grew 18.5% year-over-year to $5.83B in FY2025, up from $4.92B in the prior year. This growth reflects strong performance across the company's senior housing and healthcare real estate portfolio, driven by improved occupancy and rental rates.
VTR's FY2025 results showed broad-based improvement: revenue rose 18.5% to $5.83B, basic EPS surged 175% to $0.55, and operating cash flow grew 23.8% to $1.65B. Additionally, the company reduced its long-term debt by 3.8% to $13.01B while growing its equity base by 16.3%, signaling both earnings growth and balance sheet improvement.
VTR's financial health improved meaningfully in FY2025, with total liabilities declining 2.8% to $14.63B and stockholders' equity rising 16.3% to $12.53B. However, the company still carries significant leverage with a debt-to-equity ratio of approximately 1.17 and long-term debt of $13.01B, which warrants monitoring in a higher interest rate environment.
Based on the financial data, key risks for VTR include its elevated leverage (debt-to-equity of ~1.17 with $13.01B in long-term debt), aggressive capital deployment with $2.69B in investing outflows, and a 17.5% decline in cash reserves to $741M. These factors could pressure the company if interest rates remain high or capital markets become less accessible.
Yes, VTR's earnings per share improved dramatically in FY2025, with basic EPS rising 175% to $0.55 from $0.20 in the prior year, and diluted EPS jumping 184% to $0.54 from $0.19. This significant improvement reflects both revenue growth and improved operational efficiency across the portfolio.